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vancomycin resistant enterococci among faecal samples
from newborn admitted in ICU, maternity ward with in 24-
48 hours from two hospitals in central India. The colonization
is mainly due to antibiotic usage by the mother as well as
newborn in ICU. Antibiotics used were cefotaxime, gentam-
icin amikacin and ciproﬂoxacin. It poses a great threat to
infection control measures and complicates the selection of
empirical treatment.
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Patients with hematological malignancies who are pre-
scribed quinolone prophylaxis postchemotherapy in a
hospital with high gram-negative quinolone resistance are
at a higher risk for febrile neutropenia
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Background: Febrile neutropenia (FN) remains a major
cause of morbidity and mortality in patients receiving
chemotherapy. Major prophylactic strategies include gran-
ulocyte colony stimulating factor and antibiotics, the most
widely used of which are quinolones. While quinolone pro-
phylaxis has been shown to be effective in areas where
ﬂuoroquinolone resistance is low, this same efﬁcacy has
not been proven in areas where resistance is high. We
reviewed the efﬁcacy of quinolone prophylaxis in prevent-
ing FN in patients with leukemia and lymphoma undergoing
chemotherapy at our institute - a tertiary academic medical
center where quinolone resistance among aerobic gram-
negative bacilli (GNB) exceed 40%.
Methods: A retrospective chart review was performed on
all patients with acute leukemia and lymphoma who under-
went chemotherapy and were at high risk (>5%) of FN at our
institute between 1 October 2008 and 30 September 2009.
Demographic and clinical characteristics for each episode of
chemotherapy were collected, with the main outcome being
presence/absence of FN. Generalized estimating equation
(GEE) models were used to analyze the data to adjust for
serial autocorrelation due to repeat measurements of both
outcome and covariates for each patient.
Results: There were a total of 510 chemotherapy
episodes from 119 patients within the study period, with
median number of chemotherapy episodes being 3. Demo-
graphic and clinical characteristics - including disease stage
- were similar between patients on and off quinolone
prophylaxis. Among all patients, those on quinolone prophy-
laxis were at signiﬁcantly higher risk for both FN (OR:5.4;
95%CI:3.1-9.4; p < 0.01) and FN with bacteremia (OR:5.3;
95%CI:2.7-10.6; p < 0.01). Subgroup analysis for patients
with acute myeloid leukemia and lymphoma showed simi-
lar higher risk of FN for patients with quinolone prophylaxis
(OR:7.1; 95%CI:2.2-23.0; p < 0.01 and OR:3.8; 95%CI:1.7-8.7;
p < 0.01 respectively). All GNB isolated in these patients
were resistant to quinolones.Conclusion: In a hospital with high quinolone resis-
tance rates, quinolone prophylaxis failed to protect patients
with hematological malignancies from developing FN as
well as FN associated with bacteremia. A prospective
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ase-control study should be conducted to validate these
ndings.
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ultidrug resistant and sensitive strains of Pseudomonas
eruginosa: Establishing clonal relationship by Pulsed
ield Gel Electrophoresis and in vitro antibiotic synergy
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Background: The emergence of multidrug resistant
seudomonas aeruginosa (MDRPA) as one of the leading noso-
omial pathogens imposes a serious health threat due to
imited antibiotic options. In this study, a sample of clon-
lly distinct MDRPA and sensitive strains of Pseudomonas
eruginosa (SSPA) were tested against various antibiotics
ombinations to establish synergistic activity against these
trains.
Methods: A total of 39 retrospectively collected MDRPA
trains isolated over three years with a particular antibi-
gram (sensitive to colistin but resistant to ceftazidime,
efepime, cefoperazone, cefoperazone/sulbactam,
iproﬂoxacin, imipenem, meropenem, piperacillin,
iperacillin-tazobactam, gentamicin, netilmicin, with
arying susceptibility to amikacin) and 19 SSPA collected
rospectively were genotyped using Spe1 DNA macrorestric-
ion analysis and pulsed-ﬁeld gel electrophoresis (PFGE).
he strains were from different patients from various sites
blood, tissue, ﬂuid, catheter tip, bronchiol alveolar lavage
BAL), urine, sputum, swab, tracheal secretion and nasal
wab). Clonal relatedness was determined at ≥85% level of
imilarity and grouped into different clusters. A representa-
ive strain from each cluster was tested against 10 different
aired combinations of various antimicrobials (-lactams,
uinolone, aminoglycoside, tigecycline, rifampicin and
olistin) to establish synergistic activity against these
trains using the investigational E test ﬁxed ratio method.
Results: There were 46 distinct clones out of a total of 58
DRPA and SSPA resolved by PFGE from which 10 clonally dis-
inct strains (8 MDRPA and 2 SSPA strains) were selected for
ynergy testing. The antibiotic combination which most fre-
uently demonstrated synergy was cefepime with amikacin
4/10 strains). Other synergistic combinations were aztre-
nam with either ceftazidime or cefepime, and meropenem
ith ciproﬂoxacin (3/10 strains respectively), ceftazidime
ith either ciproﬂoxacin or amikacin (2/10 strains respec-
ively) and imipenem with ciproﬂoxacin (1/10 strains). The
ombination of ceftazidime with amikacin was antagonis-
ic in 1/10 strains. The other antibiotics combinations were
ither additive or indifferent.
Conclusion: PFGE was a useful and discriminative molec-
lar subtyping tool to establish clonal relatedness among
